Correlation Between Bioatla and Galmed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bioatla and Galmed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bioatla and Galmed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bioatla and Galmed Pharmaceuticals, you can compare the effects of market volatilities on Bioatla and Galmed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bioatla with a short position of Galmed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bioatla and Galmed Pharmaceuticals.
Diversification Opportunities for Bioatla and Galmed Pharmaceuticals
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bioatla and Galmed is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Bioatla and Galmed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galmed Pharmaceuticals and Bioatla is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bioatla are associated (or correlated) with Galmed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galmed Pharmaceuticals has no effect on the direction of Bioatla i.e., Bioatla and Galmed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bioatla and Galmed Pharmaceuticals
Given the investment horizon of 90 days Bioatla is expected to under-perform the Galmed Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Bioatla is 2.94 times less risky than Galmed Pharmaceuticals. The stock trades about 0.0 of its potential returns per unit of risk. The Galmed Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 476.00 in Galmed Pharmaceuticals on August 27, 2024 and sell it today you would lose (201.00) from holding Galmed Pharmaceuticals or give up 42.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bioatla vs. Galmed Pharmaceuticals
Performance |
| Timeline |
| Bioatla |
| Galmed Pharmaceuticals |
Bioatla and Galmed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bioatla and Galmed Pharmaceuticals
The main advantage of trading using opposite Bioatla and Galmed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bioatla position performs unexpectedly, Galmed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galmed Pharmaceuticals will offset losses from the drop in Galmed Pharmaceuticals' long position.| Bioatla vs. Pmv Pharmaceuticals | Bioatla vs. C4 Therapeutics | Bioatla vs. Nautilus Biotechnology | Bioatla vs. Century Therapeutics |
| Galmed Pharmaceuticals vs. Affimed NV | Galmed Pharmaceuticals vs. Abeona Therapeutics | Galmed Pharmaceuticals vs. Akebia Ther | Galmed Pharmaceuticals vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |